The following table presents the reconciliation of the balance sheet items to the classes of financial instruments in accordance with IFRS 7 and provides information on fair value measurement:
| XLS |
|
|
|
|
|
|
|
|
|
|
|
|
Subsequent measurement according to IAS 39 |
|
|
|||
|
€ million |
Carrying amount Dec. 31, 2013 |
Amortized cost |
At cost |
Fair value |
Carrying amount according to IAS 17 |
Non-financial items |
Fair value Dec. 31, 2013 |
|
Assets |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
980.8 |
980.8 |
– |
– |
– |
– |
980.8 |
|
Current financial assets |
2,410.5 |
80.7 |
– |
2,329.8 |
– |
– |
|
|
Held for trading |
– |
– |
– |
– |
– |
– |
– |
|
Derivatives not in a hedging relationship |
6.8 |
– |
– |
6.8 |
– |
– |
6.8 |
|
Held to maturity |
53.4 |
53.4 |
– |
– |
– |
– |
53.4 |
|
Loans and receivables |
27.3 |
27.3 |
– |
– |
– |
– |
27.3 |
|
Available-for-sale |
2,312.1 |
– |
– |
2,312.1 |
– |
– |
2,312.1 |
|
Derivatives in a hedging relationship |
10.9 |
– |
– |
10.9 |
– |
– |
10.9 |
|
Trade receivables |
2,021.4 |
2,021.4 |
– |
– |
– |
– |
|
|
Loans and receivables |
2,021.4 |
2,021.4 |
– |
– |
– |
– |
2,021.4 |
|
Current and non-current other assets |
466.2 |
115.4 |
– |
126.6 |
– |
224.2 |
|
|
Derivatives not in a hedging relationship |
2.9 |
– |
– |
2.9 |
– |
– |
2.9 |
|
Loans and receivables |
115.4 |
115.4 |
– |
– |
– |
– |
115.4 |
|
Derivatives in a hedging relationship |
123.7 |
– |
– |
123.7 |
– |
– |
123.7 |
|
Non-financial items |
224.2 |
– |
– |
– |
– |
224.2 |
|
|
Non-current financial assets |
77.8 |
15.8 |
52.3 |
9.7 |
– |
– |
|
|
Derivatives not in a hedging relationship |
– |
– |
– |
– |
– |
– |
– |
|
Held to maturity |
– |
– |
– |
– |
– |
– |
– |
|
Loans and receivables |
15.8 |
15.8 |
– |
– |
– |
– |
15.8 |
|
Available-for-sale |
57.3 |
– |
52.3 |
5.0 |
– |
– |
57.3 |
|
Derivatives in a hedging relationship |
4.7 |
– |
– |
4.7 |
– |
– |
4.7 |
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
Current and non-current financial liabilities |
3,697.9 |
3,630.8 |
– |
59.4 |
7.7 |
– |
|
|
Derivatives not in a hedging relationship |
4.0 |
– |
– |
4.0 |
– |
– |
4.0 |
|
Other liabilities |
3,630.8 |
3,630.8 |
– |
– |
– |
– |
3,916.6 |
|
Derivatives in a hedging relationship |
55.4 |
– |
– |
55.4 |
– |
– |
55.4 |
|
Finance lease liabilities |
7.7 |
– |
– |
– |
7.7 |
– |
7.7 |
|
Trade accounts payable |
1,364.1 |
1,364.1 |
– |
– |
– |
– |
|
|
Other liabilities |
1,364.1 |
1,364.1 |
– |
– |
– |
– |
1,364.1 |
|
Current and non-current other liabilities |
1,140.1 |
581.1 |
– |
2.1 |
– |
556.9 |
|
|
Derivatives not in a hedging relationship |
0.4 |
– |
– |
0.4 |
– |
– |
0.4 |
|
Other liabilities |
581.1 |
581.1 |
– |
– |
– |
– |
581.1 |
|
Derivatives in a hedging relationship |
1.7 |
– |
– |
1.7 |
– |
– |
1.7 |
|
Non-financial items |
556.9 |
– |
– |
– |
– |
556.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subsequent measurement according to IAS 39 |
|
|
|||
|
€ million |
Carrying amount Dec. 31, 2012 |
Amortized cost |
At cost |
Fair value |
Carrying amount according to IAS 17 |
Non-financial items |
Fair value Dec. 31, 2012 |
|
Assets |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
729.7 |
729.7 |
– |
– |
– |
– |
729.7 |
|
Current financial assets |
1,797.9 |
549.7 |
– |
1,248.2 |
– |
– |
|
|
Held for trading |
– |
– |
– |
– |
– |
– |
– |
|
Derivatives not in a hedging relationship |
7.8 |
– |
– |
7.8 |
– |
– |
7.8 |
|
Held to maturity |
349.7 |
349.7 |
– |
– |
– |
– |
349.7 |
|
Loans and receivables |
200.0 |
200.0 |
– |
– |
– |
– |
200.3 |
|
Available-for-sale |
1,230.1 |
– |
– |
1,230.1 |
– |
– |
1,230.1 |
|
Derivatives in a hedging relationship |
10.3 |
– |
– |
10.3 |
– |
– |
10.3 |
|
Trade receivables |
2,114.6 |
2,114.6 |
– |
– |
– |
– |
|
|
Loans and receivables |
2,114.6 |
2,114.6 |
– |
– |
– |
– |
2,114.6 |
|
Current and non-current other assets |
346.9 |
88.8 |
– |
55.3 |
– |
202.8 |
|
|
Derivatives not in a hedging relationship |
2.7 |
– |
– |
2.7 |
– |
– |
2.7 |
|
Loans and receivables |
88.8 |
88.8 |
– |
– |
– |
– |
88.8 |
|
Derivatives in a hedging relationship |
52.6 |
– |
– |
52.6 |
– |
– |
52.6 |
|
Non-financial items |
202.8 |
– |
– |
– |
– |
202.8 |
|
|
Non-current financial assets |
97.1 |
48.0 |
41.8 |
7.3 |
– |
– |
|
|
Derivatives not in a hedging relationship |
– |
– |
– |
– |
– |
– |
– |
|
Held to maturity |
30.0 |
30.0 |
– |
– |
– |
– |
30.0 |
|
Loans and receivables |
18.0 |
18.0 |
– |
– |
– |
– |
18.0 |
|
Available-for-sale |
48.7 |
– |
41.8 |
6.9 |
– |
– |
48.7 |
|
Derivatives in a hedging relationship |
0.4 |
– |
– |
0.4 |
– |
– |
0.4 |
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
Current and non-current financial liabilities |
4,453.5 |
4,284.2 |
– |
159.5 |
9.8 |
– |
|
|
Derivatives not in a hedging relationship |
4.7 |
– |
– |
4.7 |
– |
– |
4.7 |
|
Other liabilities |
4,284.2 |
4,284.2 |
– |
– |
– |
– |
4,715.7 |
|
Derivatives in a hedging relationship |
154.8 |
– |
– |
154.8 |
– |
– |
154.8 |
|
Finance lease liabilities |
9.8 |
– |
– |
– |
9.8 |
– |
9.8 |
|
Trade accounts payable |
1,288.3 |
1,288.3 |
– |
– |
– |
– |
|
|
Other liabilities |
1,288.3 |
1,288.3 |
– |
– |
– |
– |
1,288.3 |
|
Current and non-current other liabilities |
1,105.6 |
522.9 |
– |
15.0 |
– |
567.7 |
|
|
Derivatives not in a hedging relationship |
0.4 |
– |
– |
0.4 |
– |
– |
0.4 |
|
Other liabilities |
522.9 |
522.9 |
– |
– |
– |
– |
522.9 |
|
Derivatives in a hedging relationship |
14.6 |
– |
– |
14.6 |
– |
– |
14.6 |
|
Non-financial items |
567.7 |
– |
– |
– |
– |
567.7 |
|
Net gains and losses on financial instruments mainly include measurement results from currency translation, fair value adjustments, impairments and reversals of impairments as well as the recognition of premiums and discounts. Dividends and interest are not recognized in the net gains and losses on financial instruments, except for dividends and interest in the category “held for trading”. At Merck, the category “held for trading” only includes derivatives not in a hedging relationship.
The net gains and losses on financial instruments by category on the reporting date were as follows:
| XLS |
|
|
|
|
|
|
|
|
|
|
Net gains or losses |
|||
|
€ million |
Interest |
Impairments |
Reversals of impairment |
Fair value adjustments |
Disposal gains/losses |
|
Financial instrument of the category |
|
|
|
|
|
|
Held for trading |
– |
– |
– |
131.7 |
– |
|
Held to maturity |
2.5 |
– |
– |
– |
– |
|
Loans and receivables |
10.3 |
–47.2 |
42.1 |
– |
– |
|
Available-for-sale |
15.1 |
–4.1 |
– |
– |
1.6 |
|
Other liabilities |
–163.3 |
– |
– |
– |
– |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net gains or losses |
|||
|
€ million |
Interest |
Impairments |
Reversals of impairment |
Fair value adjustments |
Disposal gains/losses |
|
Financial instrument of the category |
|
|
|
|
|
|
Held for trading |
– |
– |
– |
44.4 |
– |
|
Held to maturity |
10.5 |
– |
– |
– |
– |
|
Loans and receivables |
7.9 |
–69.9 |
42.4 |
– |
– |
|
Available-for-sale |
11.4 |
–5.1 |
20.8 |
– |
0.3 |
|
Other liabilities |
–195.3 |
– |
– |
– |
– |
In 2013, foreign exchange gains of € 26.0 million resulting from receivables and payables in operating business, their economic hedging, as well as hedging of forecast transactions in operating business were recorded (2012: losses of € 60.4 million). Foreign exchange losses of € 4.3 million resulting from financial balance sheet items, their economic hedging as well as fair value fluctuations of option contracts to hedge forecast transactions were recorded (2012: gains of € 11.2 million).
The fair value of financial assets and liabilities is based on the official market prices and market values quoted on the balance sheet date (Level 1 assets and liabilities) as well as mathematical calculation models with inputs observable in the market on the balance sheet date (Level 2 assets and liabilities). Level 1 assets comprise stocks and bonds and are classified as “available-for-sale”, Level 1 liabilities comprise issued bonds and are classified as “other liabilities”. Level 2 assets and liabilities are primarily liabilities to banks classified as “other liabilities”, interest-bearing securities classified as “available-for-sale” as well as derivatives with and without hedging relationships. The fair value of interest-bearing securities is determined by discounting future cash flows using market interest rates. The fair value measurement of forward exchange contracts and currency options uses spot and forward rates as well as foreign exchange volatilities applying recognized mathematical principles. The fair value of interest rate swaps is determined with standard market valuation models using interest rate curves available in the market.
The fair values of the financial instruments disclosed in the balance sheet and the fair values deviating substantially from the carrying amount were determined as follows:
| XLS |
|
|
|
|
|
€ million |
Assets |
Liabilities |
|
Fair value determined by official prices and quoted market values (Level 1) |
1,396.5 |
3,414.3 |
|
thereof available-for-sale |
1,396.5 |
– |
|
thereof other liabilities |
– |
3,414.3 |
|
Fair value determined using inputs observable in the market (Level 2) |
1,069.6 |
563.8 |
|
thereof available-for-sale |
920.6 |
– |
|
thereof derivatives with a hedging relationship |
139.3 |
57.1 |
|
thereof derivatives without a hedging relationship |
9.7 |
4.4 |
|
thereof other liabilities |
– |
502.3 |
|
Fair value determined using inputs unobservable in the market (Level 3) |
– |
– |
|
|
|
|
|
|
|
|
|
€ million |
Assets |
Liabilities |
|
Fair value determined by official prices and quoted market values (Level 1) |
818.3 |
4,315.3 |
|
thereof available-for-sale |
818.3 |
– |
|
thereof other liabilities |
– |
4,315.3 |
|
Fair value determined using inputs observable in the market (Level 2) |
492.5 |
574.9 |
|
thereof available-for-sale |
418.7 |
– |
|
thereof derivatives with a hedging relationship |
63.3 |
169.4 |
|
thereof derivatives without a hedging relationship |
10.5 |
5.1 |
|
thereof other liabilities |
– |
400.4 |
|
Fair value determined using inputs unobservable in the market (Level 3) |
– |
– |
From an economic perspective, netting is only possible at Merck with derivatives. This possibility results from the framework agreements on derivatives trading which Merck enters into with commercial banks. However, Merck does not offset financial assets and financial liabilities in its balance sheet.
The following table presents the potential netting volume of the reported derivative financial assets and liabilities:
| XLS |
|
|
|
|
|
|
|
|
|
|
|
|
|
Potential netting volume |
|
|
|
€ million |
Gross presentation |
Saldierung |
Net presentation |
Due to master netting agreements |
Due to financial collateral |
Potential net amount |
|
Derivative financial assets |
149.0 |
– |
149.0 |
45.9 |
– |
103.1 |
|
Derivative financial liabilities |
–61.5 |
– |
–61.5 |
–45.9 |
– |
–15.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Potential netting volume |
|
|
|
€ million |
Gross presentation |
Saldierung |
Net presentation |
Due to master netting agreements |
Due to financial collateral |
Potential net amount |
|
Derivative financial assets |
73.8 |
– |
73.8 |
61.3 |
– |
12.5 |
|
Derivative financial liabilities |
–174.5 |
– |
–174.5 |
–61.3 |
– |
–113.2 |
